Skip to main content
logo
Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
15.20
-0.60 (-3.80%)
Jun 2, 2026, 5:30 PM CET

SWX:SANN Revenue

In the year 2025, Santhera Pharmaceuticals Holding AG had annual revenue of 77.19M CHF with 97.32% growth. Santhera Pharmaceuticals Holding AG had revenue of 53.17M in the half year ending December 31, 2025, a decrease of -46.55%.

Revenue
77.19M
Revenue Growth
+97.32%
P/S Ratio
2.75
Revenue / Employee
821.12K
Employees
94
Market Cap
212.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202577.19M38.07M97.32%
Dec 31, 202439.12M-64.30M-62.17%
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-
Dec 31, 2021-1.60M-16.60M-
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bachem Holding AG695.07M
Basilea Pharmaceutica AG232.38M
Idorsia219.10M
Newron Pharmaceuticals17.81M
BioVersys AG3.18M
Molecular Partners AG681.00K
Xlife Sciences AG275.31K
Addex Therapeutics172.86K
Revenue Rankings

Santhera Pharmaceuticals Holding AG News

More News